• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: FISHER & PAYKEL HEALTHCARE LTD AIRVO2 HUMIDIFIER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

FISHER & PAYKEL HEALTHCARE LTD AIRVO2 HUMIDIFIER Back to Search Results
Model Number PT101
Device Problems Loss of Power (1475); No Apparent Adverse Event (3189)
Patient Problem Low Oxygen Saturation (2477)
Event Date 09/11/2018
Event Type  malfunction  
Manufacturer Narrative
(b)(4).We are currently attempting to obtain the subject complaint device for further investigation.We will provide a follow up report once we have completed our evaluation.
 
Event Description
A healthcare facility in (b)(6) reported via a distributor to a fisher & paykel healthcare (f&p) field representative that a patient was connected to an airvo 2 humidifier when allegedly the unit turned off.It was further reported that the patient's peripheral arterial oxygen saturation (spo2) levels decreased from 90% to 82%.F&p understands that the patient received an "emergency treatment".No further patient consequence was reported.The healthcare facility further reported that the airvo 2 humidifier turned off again another day with no reported patient consequence.
 
Manufacturer Narrative
(b)(4).Method: the complaint airvo 2 humidifier was returned to fisher & paykel healthcare (f&p) in new zealand for evaluation, where it was performance tested.Result: performance test of the returned unit revealed that the unit passed all tests and was within specification.No fault was found with the returned unit.Conclusion: we are unable to determine what caused the reported event as the device was found to be operating within specification.The airvo user manual states that the "airvo is for the treatment of spontaneously breathing patients who would benefit from receiving high-flow, warmed and humidified respiratory gases" and that "the unit is not intended for life support." additionally, the airvo user manual instructs the user to "use continuous oxygen monitoring on patients who would desaturate significantly in the event of disruption to their oxygen supply.".
 
Event Description
A healthcare facility in china reported via a distributor to a fisher & paykel healthcare (f&p) field representative that a patient was connected to an airvo 2 humidifier when allegedly the the unit turned off.It was further reported that the patient's peripheral arterial oxygen saturation (spo2) levels decreased from 90% to 82%.F&p understands that the patient received an "emergency treatment".No further patient consequence was reported.The healthcare facility further reported that the airvo 2 humidifier turned off again another day with no reported patient consequence.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AIRVO2 HUMIDIFIER
Type of Device
AIRVO2 HUMIDIFIER
Manufacturer (Section D)
FISHER & PAYKEL HEALTHCARE LTD
15 maurice paykel place
east tamaki
auckland, 2013
NZ  2013
MDR Report Key7954571
MDR Text Key123376912
Report Number9611451-2018-00868
Device Sequence Number1
Product Code BTT
Combination Product (y/n)N
PMA/PMN Number
K131895
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Type of Report Initial,Followup
Report Date 09/11/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/10/2018
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberPT101
Device Catalogue NumberPT101
Device Lot Number140804
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/10/2019
Date Manufacturer Received09/11/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
F&P 900MR501 HEATED BREATHING CIRCUIT; F&P 900MR501 HEATED BREATHING CIRCUIT; F&P MR290 HUMIDIFICATION CHAMBER; F&P MR290 HUMIDIFICATION CHAMBER; F&P OPT318 NASAL CANNULA; F&P OPT318 NASAL CANNULA
-
-